ArticleCancer immunology, immunotherapy : CII2025

Characterization of the aryl hydrocarbon receptor as a potential candidate to improve cancer T cell therapies.

Valentine De Castro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.